For UK NHS Life Goes On But Medtechs Keep Eye On Brexit Implications
This article was originally published in Clinica
Executive Summary
Amidst the disingenuous claims and clever juxtapositioning of incendiary statements surrounding how much extra cash the UK NHS would get following Brexit, and the oft-repeated cri-de-guerre (“take back control”) of the UK Leave movement, the fact that the under-pressure NHS is funded and controlled by the UK alone merited hardly a mention by anti-EU campaigners.